Recombinant negative strand RNA virus expression-systems
AssigneeMount Sinai School of Medicine of the City University of New York
InventorsPeter Palese, Jeffrey D. Parvin, Mark Krystal
Life of this patent
Estimating the term…
Loading patent…
AssigneeMount Sinai School of Medicine of the City University of New York
InventorsPeter Palese, Jeffrey D. Parvin, Mark Krystal
Estimating the term…
Recombinant negative strand virus RNA templates which may be used to express heterologous gene products and/or to construct chimeric viruses are described. Influenza viral polymerase, which was prepared depleted of viral RNA, was used to copy small RNA templates prepared from plasmid-encoded sequences. Template constructions containing only the 3' end of genomic RNA were shown to be efficiently copied, indicative that the promoter lay solely within the 15 nucleotide 3' terminus. Sequences not specific for the influenza viral termini were not copied, and, surprisingly, RNAs containing termini identical to those from plus sense cRNA were copied at low levels. The specificity for recognition of the virus-sense promoter was further defined by site-specific mutagenesis. It was also found that increased levels of viral protein were required in order to catalyze both the cap-endonuclease primed and primer-free RNA synthesis from these model templates as well as from genomic lengths RNAs. This indicated that this reconstituted system had catalytic properties very similar to those of native viral RNPs. High levels of expression of a heterologous gene was obtained using the constructs and methods described.
A recombinant RNA molecule comprising a binding site specific for an RNA-directed RNA polymerase of a negative strand RNA virus, operatively linked to a heterologous RNA sequence comprising the reverse complement of an mRNA coding sequence.
A recombinant RNA molecule comprising a heterologous RNA sequence comprising the reverse complement of an mRNA coding sequence, operatively linked to a 3'-noncoding flanking sequence of an influenza vRNA containing the viral polymerase binding site, and to a 5'-noncoding flanking sequence of an influenza vRNA.
A chimeric virus comprising a negative strand RNA virus containing a heterologous RNA sequence comprising the reverse complement of an mRNA coding sequence, operatively linked to a polymerase binding site of the negative-strand RNA virus.
A chimeric virus comprising influenza virus containing a heterologous RNA sequence comprising the reverse complement of an mRNA coding sequence, operatively linked to an influenza viral polymerase binding site.
A chimeric virus comprising influenza virus containing in addition to its eight genomic segments an additional RNA segment containing a heterologous RNA sequence comprising the reverse complement of an mRNA coding sequence, operatively linked to an influenza viral polymerase binding site.
Dependencies are inferred from the claim text.